Killian discussed this a bit at the AGM. Big Pharma like to wait and are more likely to engage when there is proof of concept. Good phase II results or a product in phase III will get their interest
Ann: Cynata Annual General Meeting Presentation, page-25
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $19.42K | 101.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8208 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 9829 | 1 |
View Market Depth
| Last trade - 15.42pm 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |